A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

October 3, 2023

Study Completion Date

November 10, 2023

Conditions
Asthma
Interventions
DRUG

SAR231893

Pharmaceutical form: Solution for injection; Route of administration: Subcutaneous

DRUG

Placebo

Pharmaceutical form: Solution for injection; Route of administration: Subcutaneous

Trial Locations (55)

1769

Investigational Site Number : 6200006, Lisbon

10043

Investigational Site Number : 3800001, Orbassano

10787

Investigational Site Number : 2760002, Berlin

21001

Investigational Site Number : 8040005, Vinnytsia

23552

Investigational Site Number : 2760006, Lübeck

27003

Investigational Site Number : 7240001, Lugo / Lugo

28006

Investigational Site Number : 7240005, Madrid

29407

National Allergy and Asthma Research, LLC Site Number : 8400008, Charleston

30173

Investigational Site Number : 2760003, Hanover

34239

Sarasota Clinical Research Site Number : 8400012, Sarasota

42123

Investigational Site Number : 3800005, Reggio Emilia

42301

Allergy & Asthma Specialists, PSC Site Number : 8400004, Owensboro

46017

Investigational Site Number : 7240002, Valencia

56068

Investigational Site Number : 2760001, Koblenz

60596

Investigational Site Number : 2760005, Frankfurt am Main

61166

Investigational Site Number : 8040003, Kharkiv

68123

The Asthma and Allergy Center Site Number : 8400010, Bellevue

73034

OK Clinical Research LLC Site Number : 8400005, Edmond

76018

Investigational Site Number : 8040002, Ivano-Frankivsk

Investigational Site Number : 8040006, Ivano-Frankivsk

78006

TTS Research Site Number : 8400006, Boerne

80907

Asthma and Allergy Associates, PC Site Number : 8400011, Colorado Springs

90048

Southern California Institute for Respiratory Diseases Site Number : 8400009, Los Angeles

90230

Todd Astor MD Site Number : 8400016, Culver City

93301

Kern Allergy and Medical Research. Inc. Site Number : 8400003, Bakersfield

95117

Allergy & Asthma Associates of Santa Clara Valley Site Number : 8400001, San Jose

97504

Velocity Clinical Research, Medford Site Number : 8400007, Medford

115093

Investigational Site Number : 6430001, Moscow

115280

Investigational Site Number : 6430002, Moscow

115478

Investigational Site Number : 6430006, Moscow

117546

Investigational Site Number : 6430005, Moscow

193231

Investigational Site Number : 6430007, Saint Petersburg

194354

Investigational Site Number : 6430004, Saint Petersburg

C1414AIF

Investigational Site Number : 0320003, CABA

C1425FVH

Investigational Site Number : 0320001, CABA

S2000DEJ

Investigational Site Number : 0320004, Rosario

S2002OJP

Investigational Site Number : 0320005, Rosario

C1121ABE

Investigational Site Number : 0320002, Buenos Aires

L1S 2J5

Investigational Site Number : 1240012, Ajax

M9V 4B4

Investigational Site Number : 1240005, Toronto

G1G 3Y8

Investigational Site Number : 1240009, Québec

N8X 5A6

Investigational Site Number : 1240008, Windsor

04347

Investigational Site Number : 2760004, Leipzig

09042

Investigational Site Number : 3800006, Monserrato

6815 AD

Investigational Site Number : 5280005, Arnhem

4818 CK

Investigational Site Number : 5280001, Breda

8934 AD

Investigational Site Number : 5280002, Leeuwarden

3810-501

Investigational Site Number : 6200001, Aveiro

4810-061

Investigational Site Number : 6200007, Guimarães

4464-513

Investigational Site Number : 6200003, Matosinhos Municipality

4202-451

Investigational Site Number : 6200004, Porto

01023

Investigational Site Number : 8040008, Kyiv

01033

Investigational Site Number : 8040007, Kyiv

CB2 2QQ

Investigational Site Number : 8260001, Cambridge

EC1M 6BQ

Investigational Site Number : 8260002, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY